PatentsGlobal
CanVeer Biopharma Advances Global Patent Protection with PCT Filing for AlveoShield™ in Respiratory Disease Treatment
International patent application strengthens CanVeer’s intellectual property portfolio for novel therapies targeting chronic lung conditions including bronchopulmonary dysplasia
CanVeer Biopharma Inc. has filed an international Patent Cooperation Treaty (PCT) application for its lead investigational drug candidate AlveoShield™, marking a strategic step in securing global intellectual property rights. The filing supports CanVeer’s development of disease-modifying therapies for severe respirato…